fig1

Role of adenosine in tumor progression: focus on A<sub>2B</sub> receptor as potential therapeutic target

Figure 1. Multiple roles of A2B adenosine receptors in cancer. A2B receptor stimulation induces (1) the differentiation of human monocytes, mouse peritoneal macrophages (φ) and hematopoietic progenitor cells (HPCs) into tolerogenic dendritic cells (DCs); (2) the expansion and accumulation of MDSCs; (3) Treg differentiation, enhancing immune suppression that inhibits T-cell responses. Activation of A2B receptors on stroma cells, including tumor cells, endothelial cells and fibroblasts promotes tumor proliferation or invasion and angiogenesis. TNBC: triple negative breast cancer; VEGF: vascular endothelial growth factor; IL-8: interleukin-8; bFGF: basic fibroblast growth factor; CXCL12: C-X-C motif chemokine ligand 12; MDSCs: myeloid-derived suppressor cells

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/